Recently, platelet-rich fibrin (PRF) was described as a second-generation platelet concentrate. PRF is known as a rich source of autologous cytokines and growth factors and is universally used for tissue regeneration in clinical medicine.
Objective
The aim of the current study was to evaluate the effect of PRF on the quality and quantity of bone formation in unilateral maxillary alveolar cleft reconstruction.
Patients and Methods
Twenty-four patients with unilateral alveolar cleft underwent bone reconstruction. Patients were randomly divided into two groups. Group A consisted of patients grafted with PRF combined with autogenous anterior iliac crest bone graft. Group B patients were grafted using autogenous bone graft alone (control group). Computed tomography was performed 6 months postoperatively to assess the quality and quantity of the newly formed bone.
Results
The percentage of newly formed bone (quantity) in group A ranged from 79.74% to 88.4%, with a mean percentage of 82.6% ± 3.9%. In group B, the percentage of bone formation ranged from 60.3% to 76.4%, with a mean percentage of 68.38% ± 6.67%. There was a statistically significant increase in the percentage of newly formed bone in group A. The mean bone density (quality) of the newly formed bone was lower in group A than group B, but the difference was not statistically significant (P < .05).
Conclusions
PRF in combination with autogenous bone was beneficial in improving the volume of newly formed bone in alveolar cleft reconstruction and does not enhance bone density.
Amin KalaajiJ.L., ElanderA., FriedeH.Tibia as donor site for alveolar bone grafting in patients with cleft lip and palate: long term experience.Scand J Plast Reconstr Hand Surg.2001; 35: 35–42.
2.
AnituaE., AndiaI., ArdanzaB., NurdenP., NurdenA.T.Autologous platelets as a source of proteins for healing and tissue regeneration.Thromb Haemost.2004; 91: 4–15.
3.
BagheriS.C., BellR.B., KhanH.A.Cleft lip and palate: timing and approaches to reconstruction.Curr Ther Oral Maxillofac Surg.2012; 1: 726–749.
4.
BaqainZ.H., AnabtawiM., KarakyA.A., MalkawiZ.Morbidity from anterior iliac crest bone harvesting for secondary alveolar bone grafting: an outcome assessment study.J Oral Maxillofac Surg.2009; 67: 570–575.
5.
ChoukrounJ., DohanD.M., DissA., MouhyJ.Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2006; 101: e51–e57.
6.
DissA., ChoukrounJ., SimonpieriA., GirardM.O., SchoefflerC., DohanS.L., DohanA.J., MouhyiJ., DohanD.M.Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing.Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2006; 101: 56–60.
7.
DohanD.M., Del CorsoM., CharrierJ-B. Cytotoxicity analyses of Choukroun's platelet-rich fibrin (PRF) on a wide range of human cells: the answer to a commercial controversy.Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2007; 103: 587–593.
8.
EichhornW., BlessmannM., PohlenzP., BlakeF., BlakeG., GehrkeG., GehrkeR., GehrkeM.Primary osteoplasty using calvarian bone in patients with cleft lip, alveolus and palate.J Craniomaxillofac Surg.2009; 37: 429–133.
9.
EppleyB.L., van AalsJ., RobeyA., HavlikR., SadoveM.The spectrum of orofacial clefting.Plast Reconstr Surg.2005; 115: 101e–114e.
10.
HeL., LinY., HuX., ZhangY., WuH.A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro.Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2009; 108: 707–713.
11.
HonmaK., KobayashiT., NakajimaT., HayasiT.Computed tomographic evaluation of bone formation after secondary bone grafting of alveolar clefts.J Oral Maxillofac Surg.1999; 57: 1209–1213.
12.
HorswellB.B., HendersonJ.M.Secondary osteoplasty of the alveolar cleft defect.J Oral Maxillofac Surg.2003; 61: 1082–1090.
13.
KangY.H., JeonS.H., ParkJ.Y., ChungJ.H.Platelet rich fibrin is a bioscaffold and reservoir of growth factors for tissue regeneration.Tissue Eng Part A.2011; 17: 349–359.
14.
LarsenP.E.Reconstruction of the alveolar cleft. In Peterson's Principles of Oral and Maxillofacial Surgery.2nd ed.London: BC Decker; 2004: 859–870.
15.
MarukawaE., OshinaH., IinoG., MoritaK., OmuraK.Reduction of bone resorption by the application of platelet-rich plasma (PRP) in bone grafting of the alveolar cleft.J Craniomaxillofacial Surg.2011; 39: 278–283.
16.
MazorZ., HorowitzR.A., Del CorsoM., PrasadH.S., RohrerM.D., EhrenfestD.M.Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months.J Periodontol.2009; 80: 2056–2064.
17.
NightingaleC., WitherowH., ReidF., EdlerR.Comparative reproducibility of three methods of radiographic assessment of alveolar bone grafting.Eur J Orthod.2003; 25: 35–41.
18.
OchsM.W.Alveolar cleft bone grafting (Part II): secondary bone grafting.J Oral Maxillofac Surg.1996; 54: 83–88.
19.
OyamaT., NishimotoS., TsugawaT., ShimizuF.Efficacy of platelet-rich plasma in alveolar bone grafting.J Oral Maxillofac Surg.2004; 62: 555–558.
20.
PhurisatK., PripatnanontP.Clinical application of platelet-rich fibrin (PRF) for sinus lift bone grafting: preliminary case reports. Presented at the 1st International Bone and Dental Technology Symposium; November 12-13, 2007; Bangkok, Thailand.
21.
PradelW., TauscheE., GolloglyJ., LauerG.Spontaneous tooth eruption after alveolar cleft osteoplasty using tissue-engineered bone: a case report.Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2008; 105: 440–444.
22.
RawashdehM.A.A., TelfahH.Secondary alveolar bone grafting: the dilemma of donor site selection and morbidity.Br J Oral Maxillofac Surg.2008; 46: 665–670.
Segura-CastilloJ.L., Aguirre-CamachoH., González-OjedaA., Michel-PerezJ.Reduction of bone resorption by the application of fibrin glue in the reconstruction of the alveolar cleft.J Craniofac Surg.2005; 16: 105–112.
25.
SunithaR.V., MunirathnamN.E.Platelet -rich fibrin: evolution of a second generation platelet concentrate.Ind J Dent Res.2008; 19: 42–46.
26.
SwanM.C., GoodacreTEEE. Morbidity at the iliac crest donor site following bone grafting of the cleft alveolus.Br J Oral Maxillofac Surg.2006; 44: 129–133.
27.
TaiC-CE, SutherlandI.S., McFaddenL.Prospective analysis of secondary alveolar bone grafting using computed tomography.J Oral Maxillofac Surg.2000; 58: 1241–1249.
28.
TajimaN., SotomeS., MarukawaE., OmuraK., ShinomiyaK.A three-dimensional cell loading system using autologous plasma loaded into a porous b-tricalciumphosphate block promotes bone formation at extraskeletal sites in rats.Mater Sci Eng.2007; C27: 625–632.
29.
TakahashiT., InaiT., KochiS., FukudaM., YamaguchiT., MatsuiK., EchigoS., WatanabeM.Long-term follow-up of dental implants placed in a grafted alveolar cleft: evaluation of alveolar bone height.Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2008; 105: 297–302.
30.
TrindadeI.K., MazzottiniR., da Silva FilhoO., TrindadeI.E.K., DeboniM.Long-term radiographic assessment of secondary alveolar bone grafting outcomes in patients with alveolar clefts.Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2005; 100: 271–277.
31.
YangY.I., SeolD.L., KimH.I., ChoM.H., LeeS.J.Composite fibrin and collagen scaffold to enhance tissue regeneration and angiogenesis.Curr Appl Phys.2007; (suppl 1): 103–107.
